Cobalt speciation assay for human serum, Part II. Method validation in a study of human volunteers ingesting cobalt(II) chloride dietary supplement for 90 days

Toxicological and Environmental Chemistry

Volumn 95, Issue 4, 2013, Pages 709-718

  Kerger, Brent D ^a   Tvermoes, Brooke E ^b   Unice, Kenneth M ^c   Finley, Brent L ^b   Paustenbach, Dennis J ^b   Galbraith, David A ^b  

^a Chem Risk   (United States)

^b CARDNO CHEMRISK   (United States)

^c ChemRisk LLC   (United States)

Author keywords

cobalt; cobalt supplement; cobalt chromium alloy implants; occupational cobalt exposure

Indexed keywords

ANALYTICAL METHOD; BINDING CAPACITIES; CO CONCENTRATIONS; COBALT-CHROMIUM ALLOYS; DOSE RESPONSE RELATIONSHIPS; HUMAN VOLUNTEERS; METHOD VALIDATIONS; OCCUPATIONAL COBALT EXPOSURE;

BODY FLUIDS; CHLORINE COMPOUNDS; CHROMIUM ALLOYS; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY;

COBALT;

ALLOY; ANALYTICAL FRAMEWORK; CHROMATOGRAPHY; CHROMIUM; COBALT; CONCENTRATION (COMPOSITION); DETECTION METHOD; DOSE-RESPONSE RELATIONSHIP; FOOD SUPPLEMENTATION; INDUCTIVELY COUPLED PLASMA METHOD; INGESTION RATE; MODEL VALIDATION; MOLECULAR ANALYSIS; OCCUPATIONAL EXPOSURE; PROTEIN; SERUM; SPECIATION (CHEMISTRY); TOXICOLOGY;

EID: 84879968034     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772248.2013.792559     Document Type: Article

References (20)

1. Bar-Or, D., R. Bar-Or, L. R. Rael, D. K. Gardner, D. S. Slone, and M. L. Craun. 2005. "Heterogeneity and Oxidation Status of Commercial Human Albumin Preparations in Clinical Use." Critical Care Medicine 33: 1638-1641.
2. Bar-Or, D., J. V. Winkler, K. Vanbenthuysen, L. Harris, E. Lau, and F. W. Hetzel. 2001. "Reduced Albumin-Cobalt Binding with Transient Myocardial Ischemia After Elective Percutaneous Transluminal Coronary Angioplasty: A Preliminary Comparison to Creatinine Kinase-MB, Myoglobin, and Troponin." American Heart Journal 14: 985-991.
3. Brodner, W., P. Bitzan, V. Meisinger, A. Kaider, F. Gottsauner-Wolf, and R. Kotz. 2003. "Serum Cobalt Levels After Metal-on-Metal Total Hip Arthroplasty." Journal of Bone and Joint Surgery 85: 2168-2173.
4. Catalani, S., R. Leone, M. C. Rizetti, A. Padovani, and P. Apostoli. 2011. "The Role of Albumin in Human Toxicology of Cobalt: Contribution From a Clinical Case." ISRN Hematology, doi: 10.5402/2011/690620.
5. Ebreo, D., A. Khan, M. El-Meligy, C. Armstrong, and V. Peter. 2011. "Metal Ion Levels Decrease After Revision for Metallosis Arising from Large-Diameter Metal-on-Metal Hip Arthroplasty." Acta Orthopaedica Belgica 77: 777-781.
6. Engh, C. A. Jr., S. J. MacDonald, S. Sritulanomdha, A. Thompson, D. Naudle, and C. A. Engh. 2009. "Metal ion Levels After Metal-on-Metal Total Hip Arthroplasty: A Randomized Trial." Clinical and Orthopedic Related Research 467: 101-111.
7. Hasegawa, M., K. Yoshida, H. Wakabayashi, and A. Sudo. 2012. "Cobalt and Chromium Ion Release After Large-Diameter Metal-On-Metal Total Hip Arthroplasty." Journal of Arthroplasty 27: 990-996.
8. Jansen, H. M., S. Knollema, L. V. van der Duin, A. T. Willemsen, A. Wiersma, E. J. Franssen, F. G. Russel, J. Korf, and A. M. Paans. 1996. "Pharmacokinetics and Dosimetry of Cobalt-55 and Cobalt-57." Journal of Nuclear Medicine 37: 2082-2086.
9. Jelkmann, W., and C. Lundby. 2011. "Blood Doping and its Detection." Blood 118: 2395-2404.
10. Kerger, B. D., R. Gerads, H. Gurleyuk, K. A. Thuett, B. L. Finley, and D. J. Paustenbach. 2013. "Cobalt Speciation Assay for Human Serum, Part 1. Method for Measuring Large and Small Molecular Cobalt and Protein-Binding Capacity Using Size Exclusion Chromatography with Inductively-Coupled Plasma-Mass Spectroscopy Detection." Toxicological and Environmental Chemistry.
11. Lippi, G., G. Brocco, G. L. Salvagno, M. Montagnana, F. Dima, and G. C. Guidi. 2005. "High-Workload Endurance Training May Increase Serum Ischemia-Modified Albumin Concentrations." Clinical Chemistry and Laboratory Medicine 43: 741-744.
12. MacNair, R. D., H. Wynn-Jones, J. A. Wimhurst, A. Toms, and J. Cahir. 2013. "Metal Ion Levels not Sufficient as a Screening Measure for Adverse Reactions in Metal-On-Metal Hip Arthroplasties." Journal of Arthroplasty 28: 78-83.
13. Mothes, E., and P. Faller. 2007. "Evidence that the Principal CoII-Binding Site in Human Serum Albumin is Not at the N-Terminus: Implications on the Albumin Cobalt Binding Test for Detecting Myocardial Ischemia." Biochemistry 46: 2267-2274.
14. Nandedkar, A. K. N., P. K. Basu, and F. Friedberg. 1972. "Co++ Binding by Plasma Proteins." Bioinorganic Chemistry 2: 149-157.
15. Oettl, K., and R. E. Stauber. 2007. "Physiological and Pathological Changes in the Redox State of Human Serum Albumin Critically Influence its Binding Properties." British Journal of Pharmacology 151: 580-590.
16. Paustenbach, D., B. Tvermoes, K. Unice, B. Finley, and B. Kerger. 2013. "A review of the Health Hazards Posed by Cobalt." Critical Reviews in Toxicology 43:(4) 316-362.
17. Polyzois, L., D. Nikopoulos, L. Michos, E. Patsouris, and S. Theocharis. 2012. "Local and Systemic Toxicity of Nanoscale Debris Particles in Total Hip Arthroplasty." Journal of Applied Toxicology 32: 255-269.
18. Sadler, P. J., A. Tucker, and J. H. Viles. 1994. "Involvement of a Lysine Residue in the N-Terminal Ni2+ and Cu2+ Binding Site of Serum Albumins. Comparison with Co2+, Cd2+ and Al3+." European Journal of Biochemistry 220: 193-200.
19. Simonsen, L. O., H. Harbak, and P. Bennekou. 2012. "Cobalt Metabolism and Toxicology - A Brief Update." Science of the Total Environment 432C: 210-215.
20. Tvermoes, B. E., B. L. Finley, K. M. Unice, J. M. Otani, D. J. Paustenbach, and D. A. Galbraith. 2013. "Cobalt Whole Blood Concentrations in Healthy Adult Male Volunteers Following Two-Weeks of Ingesting a Cobalt Supplement." Food and Chemical Toxicology 53: 417-424.